Clinical Validation of the Rating Scale for Psychotic Depression (RAS-PD)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01518049|
Recruitment Status : Completed
First Posted : January 25, 2012
Last Update Posted : October 14, 2015
The aim of this study is to develop a scale to measure the severity of depression with psychotic symptoms (psychotic depression). Furthermore, we hope to detect potential biomarkers (substances in the blood) which can aid in the detection of psychotic depression.
Main hypothesis: A clinically valid rating scale measuring the severity of psychotic depression can be developed.
|Condition or disease|
|Affective Disorders, Psychotic|
|Study Type :||Observational|
|Actual Enrollment :||50 participants|
|Study Start Date :||February 2012|
|Actual Primary Completion Date :||September 2013|
|Actual Study Completion Date :||September 2014|
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01518049
|Unit for Psychiatric Research, Aalborg Psychiatric Hospital, Aarhus University Hospital|
|Aalborg, Denmark, 9000|
|Principal Investigator:||Søren D Østergaard, MD||Aahus University Hospital|